Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy.

Mönch D, Bode-Erdmann S, Kalla J, Sträter J, Schwänen C, Falkenstern-Ge R, Klumpp S, Friedel G, Ott G, Kalla C.

Oncotarget. 2018 Apr 17;9(29):20781-20794. doi: 10.18632/oncotarget.25111. eCollection 2018 Apr 17.

2.

Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: a propensity-matched analysis.

Zhang R, Kyriss T, Dippon J, Ciupa S, Boedeker E, Friedel G.

J Thorac Dis. 2018 Mar;10(3):1806-1814. doi: 10.21037/jtd.2018.02.62.

3.

Is Mistletoe Treatment Beneficial in Invasive Breast Cancer? A New Approach to an Unresolved Problem.

Fritz P, Dippon J, Müller S, Goletz S, Trautmann C, Pappas X, Ott G, Brauch H, Schwab M, Winter S, Mürdter T, Brinkmann F, Faisst S, Rössle S, Gerteis A, Friedel G.

Anticancer Res. 2018 Mar;38(3):1585-1593.

PMID:
29491089
4.

American Society of Anesthesiologists physical status facilitates risk stratification of elderly patients undergoing thoracoscopic lobectomy.

Zhang R, Kyriss T, Dippon J, Hansen M, Boedeker E, Friedel G.

Eur J Cardiothorac Surg. 2018 May 1;53(5):973-979. doi: 10.1093/ejcts/ezx436.

PMID:
29228138
5.

Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer: secondary analysis of a randomized trial.

Guberina M, Eberhardt W, Stuschke M, Gauler T, Heinzelmann F, Cheufou D, Kimmich M, Friedel G, Schmidberger H, Darwiche K, Jendrossek V, Schuler M, Stamatis G, Pöttgen C.

Ann Oncol. 2017 May 1;28(5):1084-1089. doi: 10.1093/annonc/mdx069.

PMID:
28453703
6.

[Functional Outcome after Chest Wall Stabilisation].

Kyriss T, Lenz U, Friedel G.

Zentralbl Chir. 2016 Sep;141 Suppl 1:S6-S11. doi: 10.1055/s-0042-111327. Epub 2016 Sep 8. Review. German.

PMID:
27607891
7.

[Pulmonary Metastases of Colorectal Carcinoma].

Graeter TP, Friedel G.

Zentralbl Chir. 2016 Jun;141(3):341-54. doi: 10.1055/s-0042-102272. Epub 2016 Jun 22. Review. German.

PMID:
27331291
8.

Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment: Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer.

Pöttgen C, Gauler T, Bellendorf A, Guberina M, Bockisch A, Schwenzer N, Heinzelmann F, Cordes S, Schuler MH, Welter S, Stamatis G, Friedel G, Darwiche K, Jöckel KH, Eberhardt W, Stuschke M.

J Clin Oncol. 2016 Jul 20;34(21):2526-33. doi: 10.1200/JCO.2015.65.5167. Epub 2016 May 31.

PMID:
27247220
9.

Albumin-glutaraldehyde glue for repair of superficial lung defect: an in vitro experiment.

Bures M, Höffler HK, Friedel G, Kyriss T, Boedeker E, Länger F, Zardo P, Zhang R.

J Cardiothorac Surg. 2016 Apr 12;11(1):63. doi: 10.1186/s13019-016-0443-x.

10.

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Eberhardt WE, Pöttgen C, Gauler TC, Friedel G, Veit S, Heinrich V, Welter S, Budach W, Spengler W, Kimmich M, Fischer B, Schmidberger H, De Ruysscher D, Belka C, Cordes S, Hepp R, Lütke-Brintrup D, Lehmann N, Schuler M, Jöckel KH, Stamatis G, Stuschke M.

J Clin Oncol. 2015 Dec 10;33(35):4194-201. doi: 10.1200/JCO.2015.62.6812. Epub 2015 Nov 2.

PMID:
26527789
11.

A novel, highly sensitive ALK antibody 1A4 facilitates effective screening for ALK rearrangements in lung adenocarcinomas by standard immunohistochemistry.

Gruber K, Kohlhäufl M, Friedel G, Ott G, Kalla C.

J Thorac Oncol. 2015 Apr;10(4):713-6. doi: 10.1097/JTO.0000000000000427. Erratum in: J Thorac Oncol. 2016 Apr;11(4):606.

12.

Host-integration of a tissue-engineered airway patch: two-year follow-up in a single patient.

Steinke M, Dally I, Friedel G, Walles H, Walles T.

Tissue Eng Part A. 2015 Feb;21(3-4):573-9. doi: 10.1089/ten.TEA.2014.0200. Epub 2014 Dec 11.

13.

Pulmonary adenocarcinoma occurring 5 years after resection of a primary pancreatic adenocarcinoma: a relevant differential diagnosis.

Falkenstern-Ge RF, Wohlleber M, Kimmich M, Huettl K, Friedel G, Ott G, Kohlhäufl M.

Case Rep Oncol Med. 2014;2014:841907. doi: 10.1155/2014/841907. Epub 2014 Feb 23.

14.

Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.

Gruber K, Horn H, Kalla J, Fritz P, Rosenwald A, Kohlhäufl M, Friedel G, Schwab M, Ott G, Kalla C.

J Thorac Oncol. 2014 Mar;9(3):307-15. doi: 10.1097/JTO.0000000000000068.

15.

Lung metastasis of primary alveolar soft-part sarcoma occurring 20 years after initial treatment.

Falkenstern-Ge RF, Kimmich M, Wohlleber M, Grabner A, Friedel G, Ott G, Leuschner I, Kohlhäufl M.

Case Rep Oncol Med. 2013;2013:690520. doi: 10.1155/2013/690520. Epub 2013 Nov 27.

16.

Corticomedullary differentiation and maturational arrest in thymomas.

Ströbel P, Hartmann E, Rosenwald A, Kalla J, Ott G, Friedel G, Schalke B, Kasahara M, Tomaru U, Marx A.

Histopathology. 2014 Mar;64(4):557-66. doi: 10.1111/his.12279. Epub 2013 Nov 18.

PMID:
24236644
17.

Primary pulmonary synovial sarcoma: a rare primary pulmonary tumor.

Falkenstern-Ge RF, Kimmich M, Grabner A, Horn H, Friedel G, Ott G, Kohlhäufl M.

Lung. 2014 Feb;192(1):211-4. doi: 10.1007/s00408-013-9521-1. Epub 2013 Oct 30.

PMID:
24170216
18.

Pleural mesothelioma presenting as periumbilical metastasis: the first clinical documentation.

Falkenstern-Ge RF, Kimmich M, Bode-Erdmann S, Friedel G, Ott G, Kohlhäufl M.

Case Rep Oncol Med. 2013;2013:198729. doi: 10.1155/2013/198729. Epub 2013 Apr 18.

20.

Pulmonary leiomyosarcoma mimicking glomus tumor at first biopsy and surgically treated with isolated left main bronchus resection: rare clinical documentation.

Falkenstern-Ge RF, Friedel G, Bode-Erdmann S, Ott G, Mentzel T, Kohlhäufl M, Ott MM.

Ir J Med Sci. 2013 Dec;182(4):735-8. doi: 10.1007/s11845-013-0962-6. Epub 2013 May 1.

PMID:
23636708
21.

Postoperative survival of lung cancer patients: are there predictors beyond TNM?

Friedel G, Fritz P, Goletz S, Kristen R, Brinkmann F, Dierkesmann R, Schwab M, Ott G, Dippon J, Alscher MD.

Anticancer Res. 2013 Apr;33(4):1609-19.

PMID:
23564805
22.

Learning mediastinoscopy: the need for education, experience and modern techniques--interdependency of the applied technique and surgeon's training level.

Walles T, Friedel G, Stegherr T, Steger V.

Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):450-4. doi: 10.1093/icvts/ivs494. Epub 2012 Dec 18.

23.

Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.

Walker T, Nolte A, Steger V, Makowiecki C, Mustafi M, Friedel G, Schlensak C, Wendel HP.

Eur J Cardiothorac Surg. 2013 Mar;43(3):628-33; discussion 633-4. doi: 10.1093/ejcts/ezs337. Epub 2012 Nov 14.

PMID:
23152437
24.

Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk?

Steger V, Walker T, Mustafi M, Lehrach K, Kyriss T, Veit S, Friedel G, Walles T.

Interact Cardiovasc Thorac Surg. 2012 Dec;15(6):948-53. doi: 10.1093/icvts/ivs400. Epub 2012 Sep 20.

25.

Cancer cells cue the p53 response of cancer-associated fibroblasts to cisplatin.

Schmid JO, Dong M, Haubeiss S, Friedel G, Bode S, Grabner A, Ott G, Mürdter TE, Oren M, Aulitzky WE, van der Kuip H.

Cancer Res. 2012 Nov 15;72(22):5824-32. doi: 10.1158/0008-5472.CAN-12-1201. Epub 2012 Sep 7.

26.

Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC.

Steger V, Veit S, Walker T, Friedel G, Lehrach K, Mustafi M, Walles T.

Thorac Cardiovasc Surg. 2013 Mar;61(2):109-15. doi: 10.1055/s-0032-1311529. Epub 2012 Jul 20.

PMID:
22821672
27.

TKTL-1 expression in lung cancer.

Fritz P, Coy JF, Mürdter TE, Ott G, Alscher MD, Friedel G.

Pathol Res Pract. 2012 Apr 15;208(4):203-9. doi: 10.1016/j.prp.2012.01.007. Epub 2012 Mar 24.

PMID:
22445516
28.

Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.

Boedeker E, Friedel G, Walles T.

Interact Cardiovasc Thorac Surg. 2012 May;14(5):511-5. doi: 10.1093/icvts/ivr070. Epub 2012 Feb 17. Review.

29.

Methacholine delays pulmonary absorption of inhaled β(2)-agonists due to competition for organic cation/carnitine transporters.

Gnadt M, Trammer B, Freiwald M, Kardziev B, Bayliss MK, Edwards CD, Schmidt M, Friedel G, Högger P.

Pulm Pharmacol Ther. 2012 Feb;25(1):124-34. doi: 10.1016/j.pupt.2011.12.009. Epub 2012 Jan 5.

PMID:
22245488
30.

Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?

Steger V, Spengler W, Hetzel J, Veit S, Walker T, Mustafi M, Friedel G, Walles T.

Eur J Cardiothorac Surg. 2012 Apr;41(4):880-5; discussion 885. doi: 10.1093/ejcts/ezr160. Epub 2012 Jan 10.

PMID:
22233799
31.

Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon.

Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T.

Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.

32.

[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].

Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Brüske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hübner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H; German Respiratory Society; German Cancer Society.

Pneumologie. 2011 Aug;65(8):e51-75. doi: 10.1055/s-0030-1256562. Epub 2011 Aug 9. German. No abstract available.

33.

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome.

Falkenstern-Ge RF, Kimmich M, Friedel G, Tannapfel A, Neumann V, Kohlhaeufl M.

J Cancer Res Clin Oncol. 2011 Oct;137(10):1495-8. doi: 10.1007/s00432-011-1015-z. Epub 2011 Aug 9.

PMID:
21826622
34.

Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2'-O-methyl-RNA.

Dong M, Philippi C, Loretz B, Nafee N, Schaefer UF, Friedel G, Ammon-Treiber S, Griese EU, Lehr CM, Klotz U, Mürdter TE.

Int J Pharm. 2011 Oct 31;419(1-2):33-42. doi: 10.1016/j.ijpharm.2011.07.009. Epub 2011 Jul 18.

PMID:
21782910
35.

Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study Group.

Dantonello TM, Winkler P, Boelling T, Friedel G, Schmid I, Mattke AC, Ljungman G, Bielack SS, Klingebiel T, Koscielniak E; CWS Study Group.

Pediatr Blood Cancer. 2011 May;56(5):725-32. doi: 10.1002/pbc.22862. Epub 2010 Nov 8.

PMID:
21370403
36.

Surgery of pulmonary aspergillomas in immunocompromised patients.

Kosan B, Steger V, Walker T, Friedel G, Aebert H.

Thorac Surg Sci. 2010 Mar 10;7:Doc01. doi: 10.3205/tss000020.

37.

Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society.

Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Brüske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hübner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H; German Respiratory Society; German Cancer Society.

Pneumologie. 2011 Jan;65(1):39-59. doi: 10.1055/s-0030-1255961. Epub 2010 Dec 14. No abstract available.

38.

Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts.

Haubeiss S, Schmid JO, Mürdter TE, Sonnenberg M, Friedel G, van der Kuip H, Aulitzky WE.

Mol Cancer. 2010 Jun 27;9:168. doi: 10.1186/1476-4598-9-168.

39.

Locoregional therapy.

Van Schil PE, Furrer M, Friedel G.

J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S151-4. doi: 10.1097/JTO.0b013e3181dcf754. Review.

40.

The European Society of Thoracic Surgeons lung metastasectomy project.

Van Raemdonck D, Friedel G.

J Thorac Oncol. 2010 Jun;5(6 Suppl 2):S127-9. doi: 10.1097/JTO.0b013e3181dcf59c.

41.

Indications for CT-guided percutaneous thoracic biopsy.

Bielack SS, Carrle D, Friedel G.

AJR Am J Roentgenol. 2010 May;194(5):W462; author reply W463. doi: 10.2214/AJR.09.3887. No abstract available.

PMID:
20410397
42.

Alveolar inflammation in cystic fibrosis.

Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, Döring G.

J Cyst Fibros. 2010 May;9(3):217-27. doi: 10.1016/j.jcf.2010.03.001. Epub 2010 Mar 29.

43.

[Prevention, diagnosis, therapy, and follow-up of lung cancer].

Goeckenjan G, Sitter H, Thomas M, Branscheid D, Flentje M, Griesinger F, Niederle N, Stuschke M, Blum T, Deppermann KM, Ficker JH, Freitag L, Lübbe AS, Reinhold T, Späth-Schwalbe E, Ukena D, Wickert M, Wolf M, Andreas S, Auberger T, Baum RP, Baysal B, Beuth J, Bickeböller H, Böcking A, Bohle RM, Brüske I, Burghuber O, Dickgreber N, Diederich S, Dienemann H, Eberhardt W, Eggeling S, Fink T, Fischer B, Franke M, Friedel G, Gauler T, Gütz S, Hautmann H, Hellmann A, Hellwig D, Herth F, Heussel CP, Hilbe W, Hoffmeyer F, Horneber M, Huber RM, Hübner J, Kauczor HU, Kirchbacher K, Kirsten D, Kraus T, Lang SM, Martens U, Mohn-Staudner A, Müller KM, Müller-Nordhorn J, Nowak D, Ochmann U, Passlick B, Petersen I, Pirker R, Pokrajac B, Reck M, Riha S, Rübe C, Schmittel A, Schönfeld N, Schütte W, Serke M, Stamatis G, Steingräber M, Steins M, Stoelben E, Swoboda L, Teschler H, Tessen HW, Weber M, Werner A, Wichmann HE, Irlinger Wimmer E, Witt C, Worth H; Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin und die Deutsche Krebsgesellschaft.

Pneumologie. 2010 Mar;64 Suppl 2:e1-164. doi: 10.1055/s-0029-1243837. Epub 2010 Mar 9. German. No abstract available.

PMID:
20217630
44.

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.

J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25.

PMID:
20100967
45.

[Bronchial aspergillosis].

Dobbertin I, Friedel G, Jaki R, Michl M, Kimmich M, Hofmann A, Eulenbruch HP, Weber J, Spengler W, Ott G, Kohlhäufl M.

Pneumologie. 2010 Mar;64(3):171-83. doi: 10.1055/s-0029-1215306. Epub 2010 Jan 12. German.

46.

Neoadjuvant chemoradiation with paclitaxel/carboplatin for selected Stage III non-small-cell lung cancer: long-term results of a trimodality Phase II protocol.

Hehr T, Friedel G, Steger V, Spengler W, Eschmann SM, Bamberg M, Budach W.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1376-81. doi: 10.1016/j.ijrobp.2009.03.077. Epub 2009 Oct 26.

PMID:
19864078
47.

Impact of neo-adjuvant radiochemotherapy on bronchial tissue viability.

Hampel M, Dally I, Walles T, Steger V, Veit S, Kyriss T, Friedel G.

Eur J Cardiothorac Surg. 2010 Feb;37(2):461-6. doi: 10.1016/j.ejcts.2009.08.021. Epub 2009 Sep 22.

PMID:
19775901
48.

eComment: Defective bronchial tissue homeostasis following neoadjuvant therapy for lung cancer.

Walles T, Hampel M, Dally I, Friedel G.

Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):575. doi: 10.1510/icvts.2009.203646A. No abstract available.

PMID:
19773233
49.

Generation and transplantation of an autologous vascularized bioartificial human tissue.

Mertsching H, Schanz J, Steger V, Schandar M, Schenk M, Hansmann J, Dally I, Friedel G, Walles T.

Transplantation. 2009 Jul 27;88(2):203-10. doi: 10.1097/TP.0b013e3181ac15e1.

PMID:
19623015
50.

Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.

Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G.

Ann Thorac Surg. 2009 Jun;87(6):1676-83. doi: 10.1016/j.athoracsur.2009.03.068.

PMID:
19463576

Supplemental Content

Loading ...
Support Center